Ceftazidime-avibactam versus meropenem for the treatment of nosocomial pneumonia-Reference-Cited by-同舟云学术

Ceftazidime-avibactam versus meropenem for the treatment of nosocomial pneumonia

Published:2018-03 Issue:3 Volume:18 Page:229-231
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Kalil Andre C,Klompas Michael

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference6 articles.

1. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society;Kalil;Clin Infect Dis,2016

2. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee;Vincent;JAMA,1995

3. Trend in ventilator-associated pneumonia rates between 2005 and 2013;Metersky;JAMA,2016

4. Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial;Torres;Lancet Infect Dis,2017

5. Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of a KPC-84 harboring Klebsiella pneumoniae ST11 clinical isolate with ceftazidime-avibactam resistance;European Journal of Clinical Microbiology & Infectious Diseases;2024-08-07

2. Identification of a Novel KPC Variant, KPC-204, Conferring Resistance to Both Carbapenems and Ceftazidime–Avibactam in an ST11 Klebsiella pneumoniae Strain;Microorganisms;2024-06-13

3. Bacterial Infections in Intensive Care Units: Epidemiological and Microbiological Aspects;Antibiotics;2024-03-05

4. Ceftazidime/Avibactam and Meropenem/Vaborbactam for the Management of Enterobacterales Infections: A Narrative Review, Clinical Considerations, and Expert Opinion;Antibiotics;2023-10-09

5. Efficacy and safety of ceftazidime-avibactam compared to other antimicrobials for the treatment of infections caused by carbapenem-resistant Klebsiella pneumoniae strains, a systematic review and meta-analysis;Microbial Pathogenesis;2023-06